Alltrna company information, Employees & Contact Information

Alltrna Appoints David Hava, Ph.D., Chief Scientific Officer to Drive Strategic Pipeline Advancement of tRNA Medicines PR Newswire

Flagship Pioneering's Alltrna sheds staff as it readies for clinical debut Fierce Biotech

Nonsense! Engineered tRNAs Offer Universal Solutions to Stop Codon Diseases Inside Precision Medicine

Alltrna Presents Preclinical Data Demonstrating Proof-of-Concept for First tRNA Development Candidate Yahoo Finance

Alltrna plans to tackle rare diseases using tRNA-based therapies Pharmaceutical Technology

For Alltrna CEO Michelle Werner, Making Better Drugs Is Personal BioSpace

Alltrna’s engineered tRNA restores protein production in MMA and PKU models BioWorld MedTech

New tRNA tech aims to rewrite rare disease treatment Drug Target Review

Alltrna Appoints Dr. Nerissa Kreher as Chief Medical Officer to Advance tRNA Medicines for Rare Diseases PR Newswire

Alltrna Unveils $109M to Make tRNA a Universal Therapy for Genetic Diseases MedCity News

Alltrna Appoints Chris Henderson, Ph.D., as Chief Scientific Officer citybiz

Alltrna raises $109M for ‘transfer RNA’ drug vision BioPharma Dive

Her son’s DMD diagnosis shook her world. As a biotech CEO, it was also an epiphany for better rare disease R&D. Pharma Voice

Flagship startup Alltrna raises $109M for tRNA therapies that restore missing proteins Endpoints News

Flagship's Alltrna collects $109M as it passes go to Stop Codon Disease Fierce Biotech

Alltrna Announces Series B Raise of $109 Million to Advance tRNA Medicines for Stop Codon Disease PR Newswire

Flagship Pioneering Launches Alltrna to Unlock Transfer RNA Biology and Treat Thousands of Diseases with a Single tRNA Medicine PR Newswire

Alltrna Announces Updates to Its Board of Directors PR Newswire

Alltrna Announces Formation of Scientific Advisory Board with World-Leading RNA Experts PR Newswire

Flagship unveils its next RNA bet with $50M for Alltrna to explore thousands of genetic diseases using transfer RNA Fierce Biotech

No-nonsense: Alltrna Touts tRNA Therapeutics to Treat Thousands of Diseases Genetic Engineering and Biotechnology News

Moderna founder unveils new drug company focused on a different kind of RNA BioPharma Dive

My son’s rare disease diagnosis spurred me to ditch Big Pharma for a biotech startup Fortune

From Pennsylvania to Alltrna: Michelle Werner’s journey to tRNA BioXconomy

In Conversation with Michelle Werner Inside Precision Medicine

Arch-backed HC Bioscience closes doors after seeing early data for tRNA asset Fierce Biotech

Flagship Debuts Alltrna to Unlock the Mysteries of tRNA BioSpace

Will tRNA therapy be the next big thing in genetic disease treatment? Labiotech.eu

Tuning the Therapeutic Properties of tRNAs To Treat Rare Diseases Technology Networks

Moving beyond protein translation with tRNA BioProcess International

Flagship Pioneering Bolsters Executive Team with Appointment of Michelle C. Werner as CEO-Partner and CEO of Alltrna PR Newswire

With $50M, Flagship Pioneering makes another big RNA play: Alltrna The Business Journals

Flagship Pioneering’s new venture is betting on tRNA to treat ‘thousands of diseases’ TechCrunch

Breakthrough therapies have given Duchenne muscular dystrophy families like mine hope — and new fears statnews.com

Takeda, Arch back hC Bioscience with $24M for transfer RNAs, following Flagship into the field Fierce Biotech

C&EN’s 10 Start-Ups to Watch for 2022 Chemical & Engineering News

Flagship Pioneering unveils another RNA startup, backing it with $50 million The Boston Globe

Phenylketonuria Clinical Trial Pipeline Appears Robust With GlobeNewswire

Frank Zhang returns to Legend BioCentury